Perspective Therapeutics (CATX) Net Shares Issued and Repurchased (2011 - 2025)

Perspective Therapeutics has disclosed Net Shares Issued and Repurchased across 15 years of filings, most recently posting $4.1 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased rose 37.3% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $4.1 million (up 37.3% YoY), while the FY2025 annual figure was $4.1 million, up 37.3% from the prior year.
• Net Shares Issued and Repurchased came in at $4.1 million for Q4 2025 at Perspective Therapeutics, up from $3.0 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $21.7 million in Q4 2023 to a low of $112500.0 in Q4 2021.
• Average Net Shares Issued and Repurchased over 5 years is $4.2 million, with a median of $3.0 million recorded in 2021.
• Year-over-year, Net Shares Issued and Repurchased soared 17900.0% in 2021 and sank 86.18% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $112500.0 in 2021, then surged by 3664.44% to $4.2 million in 2022, then jumped by 411.58% to $21.7 million in 2023, then slumped by 86.18% to $3.0 million in 2024, then jumped by 37.3% to $4.1 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $4.1 million in Q4 2025, $3.0 million in Q4 2024, and $21.7 million in Q4 2023.